Catalyst Wire Dossier Catalyst Wire Dossier

TRV027

· Trevena Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TRV027, covering 2018-07-26 to 2018-07-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Explore the Efficacy of TRV027 in Patients Hospitalized for Acute Decompensated Heart Failure [Phase 2]

See pricing